About Navatio Pharma
Navatio Pharma is a Healthcare company. Pharmacovigilance, medical writing, and regulatory services in healthcare sectors. The company has 10 employees. Its Indian entity Navatio Pharma Solutions Private Limited reported revenue of βΉ3.08 Cr. Navatio Pharma offers products and services including Pharmacovigilance Services and Medical Writing Services. Its focus areas include Medical Devices, Materiovigilance, Device Safety Services and Biotechnology.
Company details
Navatio Pharma is recognized as a global contract research organization that specializes in pharmacovigilance and related fields, with services tailored to pharmaceutical and biotech needs. Comprehensive solutions for drug safety, medical device monitoring, and regulatory compliance are delivered by its team of experts. Over 35 years of experience and a global reach enable support for clients in establishing robust systems and managing risks. Dedication to transparency and quality is maintained through customized strategies that align with international standards, ensuring advancements in healthcare safety and efficiency.
- Employees 10
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website navatiopharma.com
- Social LinkedIn Instagram
- Legal Name Navatio Pharma Solutions Private Limited
- Date of Incorporation 13 Feb, 2019
- Jurisdiction Hyderabad, Telangana, India
- Indian entity revenue₹3.08 Cr
FY 2024 · +49% YoY
- Indian entity net profit₹12.4 Lakh
FY 2024 · 4% margin
- Indian entity EBITDA₹19.5 Lakh
FY 2024 · 6% margin
- Employee Count10
Associated legal entities of Navatio Pharma
Navatio Pharma operates through Navatio Pharma Solutions Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Navatio Pharma Solutions Private Limited CIN U74999TG2019PTC130528 | Active | 13 Feb 2019 | Hyderabad, Telangana | ₹3.1 Cr | 10 | 2 | View details |
Products & Services of Navatio Pharma
Navatio Pharma offers a comprehensive portfolio of products and services, including Pharmacovigilance Services and Medical Writing Services.
Comprehensive drug safety solutions are offered by Navatio Pharma to ensure regulatory compliance and patient well-being through monitoring and reporting.
Regulatory-compliant medical and scientific writing is provided by Navatio Pharma for safety reports and clinical documents to support healthcare organizations.
Board of directors of Navatio Pharma Solutions Private Limited (Navatio Pharma)
Navatio Pharma Solutions Private Limited is the primary company behind Navatio Pharma. The board of Navatio Pharma Solutions Private Limited currently have 2 directors; the longest-serving is Praneetha Akuthota, appointed in 2022. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Praneetha Akuthota DIN 09514398 | Director | 22 Feb 2022 | 4 yrs 8 mo | Navatio Pharma Solutions Private Limited |
| Kalyanker Ashwini DIN 09792035 | Director | 31 Jan 2023 | 3 yrs 9 mo | Navatio Pharma Solutions Private Limited |
People of Navatio Pharma
1 people are tracked at Navatio Pharma (1 in leadership); the tracked headcount is 10.
| Name | Role | Group |
|---|---|---|
Sai Kalyaanker | CEO and Founder | Leadership |
Complete people profiles for Navatio Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Navatio Pharma
Figures of Navatio Pharma Solutions Private Limited, the primary company behind Navatio Pharma, for FY 2024. Revenue was ₹3.08 Cr (+49% year on year). Net profit was ₹12.4 Lakh (4% margin). EBITDA was ₹19.5 Lakh (6% margin).
- ₹3.08 CrRevenue · FY 2024 · +49% YoY
- ₹12.4 LakhNet profit · 4% margin
- ₹19.5 LakhEBITDA · 6% margin
- ₹1 LakhPaid-up capital
- 10Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Navatio Pharma Solutions Private Limited are on its company page.
Detailed financial statements for Navatio Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Navatio Pharma
Navatio Pharma has 10 employees.
The primary company behind Navatio Pharma, Navatio Pharma Solutions Private Limited, reported revenue of βΉ3.08 Cr for FY 2024, up 49% year on year.
Navatio Pharma is recognized as a global contract research organization that specializes in pharmacovigilance and related fields, with services tailored to pharmaceutical and biotech needs. Comprehensive solutions for drug safety, medical device monitoring, and regulatory compliance are delivered by its team of experts. Over 35 years of experience and a global reach enable support for clients in establishing robust systems and managing risks. Dedication to transparency and quality is maintained through customized strategies that align with international standards, ensuring advancements in healthcare safety and efficiency.
Navatio Pharma offers Pharmacovigilance Services and Medical Writing Services.
Navatio Pharma operates through Navatio Pharma Solutions Private Limited.
The legal entities of Navatio Pharma currently have 2 directors, including Kalyanker Ashwini, Praneetha Akuthota.
